Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2023 07:11 ET | Source: H+H International A/S

Conclusion of share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the...
January 04, 2023 07:08 ET | Source: Research and Markets

Global Tangential Flow Filtration Market Report 2023: Rising Need For Protein Separation For The Preparation Of Recombinant Proteins Bolsters Sector

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Tangential Flow Filtration Market Size, Share & Industry Trends Analysis Report By Technology (Microfiltration, Ultrafiltration, and...
January 04, 2023 07:07 ET | Source: GoLogiq Inc. and Emerging Markets Consulting, LLC.

Emerging Markets Report: Bigger and Better

An Emerging Markets Sponsored Commentary ORLANDO, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- GoLogiq, Inc. (OTC: GOLQ), a global provider of mobile fintech solutions for digital transformation and...
January 04, 2023 07:05 ET | Source: Downing Strategic Microcap Investment Trust plc

DSM: Net Asset Value(s)

Downing Strategic Micro-Cap Investment Trust Plc LEI Code: 213800QMYPUW4POFFX69 Net Asset Values The Company announces the following, all of which is unaudited: Total Assets - including current period...
January 04, 2023 07:05 ET | Source: Aravive, Inc.

Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian Cancer

Topline data expected mid-2023Potential Biologics License Application (BLA) submission end of 2023 HOUSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, the “Company”), a late...
January 04, 2023 07:03 ET | Source: Research and Markets

OTC/DTC Infectious Disease Diagnostics Market Report 2023: New Sampling Technology and Rapid and Multiplex Tests Present Opportunities

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
January 04, 2023 07:02 ET | Source: Harboes Bryggeri A/S

Major shareholder announcement

Major shareholder announcement Olav W. Hansen A/S announces pursuant to the Capital Markets Act section 38, subsection 1, that the company after purchasing 331 pcs. b shares in Harboes Bryggeri A/S...
January 04, 2023 07:02 ET | Source: The Riverside Company

Riverside’s Exit of SureWerx is a Sure Success for Everyone Involved

CLEVELAND, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The Riverside Company, a global private investor focused on the smaller end of the middle market, has sold its investment in SureWerx, a leading North...
January 04, 2023 07:02 ET | Source: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Provides Business Update and 2023 Outlook

― FTX-6058 granted Fast Track Designation for sickle cell disease (SCD) from FDA in December 2022 ―― Completed enrollment in 6 mg and 2 mg dose cohorts of the Phase 1b trial of FTX-6058 in SCD;...
January 04, 2023 07:01 ET | Source: Nurix Therapeutics, Inc.

Nurix Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat...

1 ...63199 63200 63201 ...316286